protein subunit vaccine (National Institute of Infectious Diseases Japan)

N/A

Report date: 2025/01/26 18:01:53

Base Information

Drug Nameprotein subunit vaccine (National Institute of Infectious Diseases Japan)

Drug Alias NameSARS-CoV-2 vaccine (National Institute of Infectious Diseases Japan)

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionCoronavirus spike glycoprotein modulators

TargetsCoronavirus spike glycoprotein

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNational Institute of Infectious Diseases, Tokyo, Japan

China Registration ClassN/A

Develop Information

Active CompaniesNational Institute of Infectious Diseases, Tokyo, Japan

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A